<DOC>
	<DOCNO>NCT00595790</DOCNO>
	<brief_summary>The study investigate rapid immunization regime Japanese Encephalitis vaccine IC51 ( JE-PIV ) healthy subject age &gt; = 18 year</brief_summary>
	<brief_title>Rapid Immunization Study Japanese Encephalitis Vaccine IC51</brief_title>
	<detailed_description>This multicenter , observer blind , control , randomize phase 3 study . The study population consist healthy male female volunteer , age least 18 year . Approximately 375 volunteer enrol approximately 2 3 site .</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 year age Written inform consent obtain prior study entry History clinical manifestation flavivirus infection History vaccination Japanese encephalitis ( JE ) , Yellow fever Dengue fever ( antiJEV neutralize antibody titer &gt; = 1:10 baseline acceptable inclusion , subject part safety population , analyze immunogenicity perprotocol analysis ) Use investigational nonregistered drug vaccine addition study vaccine study period within 30 day precede first dose study vaccine Immunodeficiency include postorgantransplantation immunosuppressive therapy A family history congenital hereditary immunodeficiency History autoimmune disease Any acute infection within 4 week prior enrollment Infection HIV , Hepatitis B Hepatitis C Pregnancy , lactation unreliable contraception female subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>